| Name | N2-[(4-Chlorophenyl)sulfonyl]-5,5,5-trifluoro-D-norvalinamide |
|---|---|
| Synonyms |
(R)-2-(4-chlorophenyl)-pyrrolidine
(R)-2-(4-chlorophenylsulfonamido)-5,5,5-trifluoropentanamide |
| Molecular Formula | C11H12ClF3N2O3S |
|---|---|
| Molecular Weight | 344.73800 |
| Exact Mass | 344.02100 |
| PSA | 98.63000 |
| LogP | 4.43610 |
|
~90%
1146699-67-3 |
| Literature: Bristol-Myers Squibb Company Patent: US2010/240719 A1, 2010 ; Location in patent: Page/Page column 12; 13 ; |
|
~86%
1146699-67-3 |
| Literature: Hanson, Ronald L.; Johnston, Robert M.; Goldberg, Steven L.; Parker, William L.; Goswami, Animesh Organic Process Research and Development, 2013 , vol. 17, # 4 p. 693 - 700 |
|
~%
1146699-67-3 |
| Literature: Hanson, Ronald L.; Johnston, Robert M.; Goldberg, Steven L.; Parker, William L.; Goswami, Animesh Organic Process Research and Development, 2013 , vol. 17, # 4 p. 693 - 700 |
|
~%
1146699-67-3 |
| Literature: Hanson, Ronald L.; Johnston, Robert M.; Goldberg, Steven L.; Parker, William L.; Goswami, Animesh Organic Process Research and Development, 2013 , vol. 17, # 4 p. 693 - 700 |
| Precursor 5 | |
|---|---|
| DownStream 1 | |